Likewise, IgE reactivity against the M. sympodialis extract was detected significantly more often in severe (i.e., 60%) compared to moderate AD patients (i.e., 39%) with 45% of the 179 AD patients being positive on average (p<0.01) (Table 2). This evidence concerns the gene IGHE and Alzheimer disease.